Skip to Content

Emergent Health Corp EMGE

Morningstar Rating
$0.00 0.00 (7.14%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EMGE is trading at a 130% premium.
Price
$0.00
Fair Value
$6.68
Uncertainty
Extreme
1-Star Price
$7.57
5-Star Price
$3.94
Economic Moat
Jqyjq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EMGE is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$640,426.67
Volume/Avg
355,000 / 2.8 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Emergent Health Corp develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim a nutrient that enhances the immune system, nourishes stem cells and maintains health; Neuvitale which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest a diet aid that controls appetite in the brain and stomach; and EmergentO2, a water oxygenator, which increases oxygen in the bloodstream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, online, and various other retail outlets throughout the United States and internationally.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
EMGE
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
EMGE
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
EMGE
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRQkvdnpltkhNkkqymh$78.2 Bil
ZTS
Zoetis Inc Class ANyrlfknfVqhq$78.0 Bil
HLN
Haleon PLC ADRBbyqfnrkYcs$37.4 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRCtsfcdwRwrv$19.1 Bil
VTRS
Viatris IncVpwgctxtfJftlp$12.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRHnbhgdzftBnfc$11.8 Bil
CTLT
Catalent IncXvhvsydwFphjzv$9.9 Bil
PRGO
Perrigo Co PLCTmndcnzrTfz$3.8 Bil
CURLF
Curaleaf Holdings IncPbtsndyQyh$3.5 Bil
PBH
Prestige Consumer Healthcare IncTzkqhztbtLxftny$3.2 Bil

Sponsor Center